Skip to content

Prevalence of thyroid disease in diabetics.

Prevalence of Subclinical hypothyroidism in Indian patients with Type 2 diabetes mellitus-a real world multi-centric study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051417
Enrollment
216
Registered
2023-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism Health Condition 2: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

ACP-India Chapter
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Indian adult patients with type 2 DM or with FBS >126 mg/dL or HbA1C >6.5% Those who will give consent to be a part of the study and consented to the utilization of their anonymized data for research.

Exclusion criteria

Exclusion criteria: Any other type of diabetes (Type 1 DM/Gestational/LADA/MODY) Patients with a history of receiving any drug that may have caused thyroid dysfunction or had an acute illness that affected their thyroid hormone status or subacute thyroiditis are to be excluded from the study. Pregnant/lactating women Those who do not give consent

Design outcomes

Primary

MeasureTime frame
To determine the prevalence of subclinical hypothyroidism among Indian patients with Type 2 Diabetes MellitusTimepoint: 3 months

Secondary

MeasureTime frame
To assess the association of subclinical hypothyroidism in type 2 Diabetes Mellitus patients with gender and age To compare the thyroid function tests in diabetic Indian patients and to investigate whether any diabetic complicationTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Anuj Maheshwari

Hind Institute Of Medical Sciences

dranujm@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026